Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (221-230 of 368) with videos related to

Pageof 37
Sort By:
Revista Espanola De Cardiologia (English Ed.)|July 15, 2015
Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA StudyVivencio Barrios, Carlos Escobar, Luis Prieto, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 9, 2007
Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in SpainVivencio Barrios, Carlos Escobar, Alberto Calderón, et al.
Cirugia Espanola|July 16, 2014
Traumatic Horner syndrome without vascular injuryMaría Pilar Guillén-Paredes, Benito Flores-Pastor, Carlos Escobar, et al.
Biomarkers in Medicine|May 7, 2014
Clinical implications of different biomarkers in elderly patients with heart failureIrene Sanchez, Sergio Santana, Carlos Escobar, et al.
Revista Espanola De Cardiologia (English Ed.)|October 4, 2016
Concomitant Rivaroxaban and Dronedarone Administration in Patients With Nonvalvular Atrial FibrillationCarlos Escobar, Martín Arceluz, Rosa Montes de Oca, et al.
Cardiovascular Therapeutics|May 10, 2008
Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE StudyVivencio Barrios, Carlos Escobar, Mariano de la Figuera, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 28, 2021
Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI studyVivencio Barrios, Carlos Escobar, Vicente Arrarte, et al.
Future Cardiology|June 29, 2017
Common atrial flutter catheter ablation without discontinuing oral anticoagulationCarlos Escobar, Sergio Castrejón, Rosa Montes de Oca, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2008
Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA StudyCarlos Escobar, Vivencio Barrios, Alberto Calderón, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 28, 2010
Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara studyAlberto Calderón, Vivencio Barrios, Carlos Escobar, et al.
Pageof 37

Showing results (221-230 of 368) with videos related to

Sort By:
Pageof 37
Revista Espanola De Cardiologia (English Ed.)|July 15, 2015
Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA StudyVivencio Barrios, Carlos Escobar, Luis Prieto, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 9, 2007
Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in SpainVivencio Barrios, Carlos Escobar, Alberto Calderón, et al.
Cirugia Espanola|July 16, 2014
Traumatic Horner syndrome without vascular injuryMaría Pilar Guillén-Paredes, Benito Flores-Pastor, Carlos Escobar, et al.
Biomarkers in Medicine|May 7, 2014
Clinical implications of different biomarkers in elderly patients with heart failureIrene Sanchez, Sergio Santana, Carlos Escobar, et al.
Revista Espanola De Cardiologia (English Ed.)|October 4, 2016
Concomitant Rivaroxaban and Dronedarone Administration in Patients With Nonvalvular Atrial FibrillationCarlos Escobar, Martín Arceluz, Rosa Montes de Oca, et al.
Cardiovascular Therapeutics|May 10, 2008
Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE StudyVivencio Barrios, Carlos Escobar, Mariano de la Figuera, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 28, 2021
Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI studyVivencio Barrios, Carlos Escobar, Vicente Arrarte, et al.
Future Cardiology|June 29, 2017
Common atrial flutter catheter ablation without discontinuing oral anticoagulationCarlos Escobar, Sergio Castrejón, Rosa Montes de Oca, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2008
Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA StudyCarlos Escobar, Vivencio Barrios, Alberto Calderón, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 28, 2010
Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara studyAlberto Calderón, Vivencio Barrios, Carlos Escobar, et al.
Pageof 37